Hidejiro Torigoe - Concepedia

Author

Hidejiro Torigoe

Okayama University ORCID

Also Known As

H. Torigoe, HIDEJIRO TORIGOE, Hidejiro TORIGOE, Hidejiro Torigoe, Hidejiro torigoe, Torigoe, Hidejiro

Publications

679

Citations

H-Index

Concepts

All Affiliations

Okayama University Okayama University of Science Gunma University Tokyo Medical University Universitas Gadjah Mada

About

Hidejiro Torigoe is an author at Okayama University specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	80
2	Engineering	1	1	21
3	Health Sciences	1	1	33
4	Cell Biology	1	1	26
5	Immunology	1	1	26

Hidejiro Torigoe

Publications

641

Citations

H-Index

Page 1

	Year	Citations
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in <i>EGFR</i> -Mutant Non–Small Cell Lung Cancer Cells Kei Namba, Kazuhiko Shien, Yuta Takahashi, Molecular Cancer Research	2018	93
Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer Hiroki Sato, Hiromasa Yamamoto, Masakiyo Sakaguchi, Cancer Science	2018	65
Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features Hiroki Sato, Kazuhiko Shien, Shuta Tomida, Scientific Reports	2017	60
Newly developed anti‐S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis Rie Kinoshita, Hiroki Sato, Akira Yamauchi, International Journal of Cancer	2018	50
Antitumor activity of pan‐<scp>HER</scp> inhibitors in <scp>HER</scp>2‐positive gastric cancer Takahiro Yoshioka, Kazuhiko Shien, Kei Namba, Cancer Science	2018	42
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki, PLoS ONE	2017	41
Acquired resistance mechanisms to afatinib in <i><scp>HER</scp>2</i>‐amplified gastric cancer cells Takahiro Yoshioka, Kazuhiko Shien, Tatsuaki Takeda, Cancer Science	2019	37
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway Tomoaki Ohtsuka, Masakiyo Sakaguchi, Hiromasa Yamamoto, Scientific Reports	2016	35
Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis Yuta Takahashi, Kazuhiko Shien, Shuta Tomida, Cancer Science Surgical OncologyGeneticsPathologyOncologyTumor Heterogeneity	2018	33
Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer Haiyang Chen, Kazuhiko Shien, Ken Suzawa, Oncology Letters	2017	28

Page 1